First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 181.02 USD 0.37%
Updated: Mar 28, 2024

ROE
Return on Equity

34.9%
Current
82%
Average
-29.6%
Industry
Positive for the last year
34.9%
Positive average
82%
Worse than average
Better than industry value

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
34.9%
=
Net Income
4.8B
/
Equity
13.8B

ROE Across Competitors

ROE Comparison
Abbvie Inc Competitors

Country US
Market Cap 319.7B USD
ROE
35%
Country US
Market Cap 153.2B USD
ROE
136%
Country US
Market Cap 108.4B USD
ROE
23%
Country US
Market Cap 105.1B USD
ROE
16%
Country US
Market Cap 91.4B USD
ROE
26%
Country AU
Market Cap 139.1B AUD
ROE
15%
Country US
Market Cap 43.1B USD
ROE
-28%
Country US
Market Cap 41.6B USD
ROE
-29%
Country US
Market Cap 31.2B USD
ROE
8%
Country KR
Market Cap 40.1T KRW
ROE
14%
Country IE
Market Cap 26.6B USD
ROE
9%

ROE Distribution

ROE Distribution
Biotechnology Industry

Profitability Report

View the profitability report to see the full profitability analysis for Abbvie Inc.

See Also

Discover More
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
34.9%
=
Net Income
4.8B
/
Equity
13.8B
What is the ROE of Abbvie Inc?

Based on Abbvie Inc's most recent financial statements, the company has ROE of 34.9%.